Platelia sars cov 2 total ab
The Platelia SARS-CoV-2 Total Ab is an in vitro diagnostic test for the qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma samples. It is designed to aid in the diagnosis of COVID-19 infection.
4 protocols using platelia sars cov 2 total ab
Contrivance of SARS-CoV-2 Antibody DBS Specimens
DBS Elution and Antibody Assay Protocol
Quantifying SARS-CoV-2 Antibody Profiles
stored at –80°C to avoid repeated freeze-thaw cycles. Complement components and
potential infectious viruses in serum samples were heated-deactivated at 56°C
for 30 min immediately before use.
Titers of S protein antibodies and the presence of N protein antibodies were
determined using Ortho Anti-SARS-CoV-2 total immunoglobulin (Ig) (Vitros, Cat#
6199922) and Platelia SARS-CoV-2 Total Ab (Biorad, Cat# 72710), respectively. In
addition, the serum capacities of inhibiting RBD–ACE2 binding were determined
using SARS-CoV-2 surrogate virus neutralization kits (Genscript, Cat#
L00847).
SARS-CoV-2 Antibody Detection Assays
SARS-CoV-2 Ab ELISA Test (Wantai, Beijing, China)—for simultaneous detection of three antibody isotypes (IgM, IgA, IgG) directed to the S1-RBD;
SARS-CoV-2 Ab IgM ELISA (Wantai, Beijing, China)—for detecting the IgM isotype of specific antibodies directed to the S1-RBD;
Anti-SARS-CoV-2 IgA ELISA (EUROIMMUN, Lübeck, Germany)—for semi-quantitative in vitro evaluation of anti-SARS-CoV-2 IgA antibodies directed to the S1 protein;
Anti-SARS-CoV-2 ELISA (IgG) (EUROIMMUN, Lübeck, Germany)—for semi-quantitative in vitro evaluation of anti-SARS-CoV-2 IgG antibodies directed to the S1 protein. The test was used in 2020, and since December 2020, anti-SARS-CoV-2 QuantiVac ELISA (IgG) (EUROIMMUN, Lübeck, Germany) quantitative test was in use;
iFlash–SARS-CoV-2 IgG—chemiluminescence test for semi-quantitative detection of anti-SARS-CoV-2 IgG antibodies (SHENZHEN YHLO BIOTECH CO., Shenzhen, China);
Bio-Rad Platelia SARS-CoV-2 Total Ab—for simultaneous detection of IgG, IgA, and IgM antibodies directed to the nucleocapsid (anti-N).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!